PATENT CLAIM ANALYSIS

Application Number: 15903337
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "256000"]

Abstract:
This invention is directed to a compound of formula (I): wherein R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising the compound, intermediates and processes for making said compounds, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD) and age-related macular degeneration (AMD).

Claim (Index 1):
A compound of formula (I): wherein R1 is hydrogen or C 1 -C 6 alkyl; R2 is hydrogen, halogen or C 1 -C 3 alkyl; and R3 is hydroxyalkyl; or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.43396
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13439511', '15258892', '12570355', '12062641', '14150049']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7471359109852992
- 35 USC 102 Novelty (BERT): 0.4887317014108085
- Combined Prediction Score: 0.7212954900278501
- Mean Citation Score: 230.37544
- Max Citation Score: 241.965
- Similarity Product: 218.45274288475508

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test